MCRB SERES THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Credit Agreement and FDA Approval Seres Therapeutics, Inc. entered into a Credit Agreement and Guaranty for a term loan facility of $250 million, with net proceeds of $50 million, and received FDA approval for VOWSTTM.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC